메뉴 건너뛰기




Volumn 172, Issue , 2008, Pages 117-140

Alterations of dopamine and serotonin transmission in schizophrenia

Author keywords

dopamine (DA); interactions; neurotransmitters; schizophrenia; Serotonin (5 HT)

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; ALTANSERIN; AMISULPRIDE; AMPEROZIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CLOZAPINE; CP 809 101; DOPAMINE; EPLIVANSERIN; FLESINOXAN; GW 742457; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; QUIPAZINE; RACLOPRIDE C 11; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; SETOPERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLINANSERIN; WAY 163909; ZIPRASIDONE; ZOTEPINE;

EID: 50349091367     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00906-0     Document Type: Review
Times cited : (66)

References (252)
  • 1
    • 0036692399 scopus 로고    scopus 로고
    • Recent evidence for dopamine abnormalities in schizophrenia
    • Abi-Dargham A. Recent evidence for dopamine abnormalities in schizophrenia. Eur. Psychiatry 17 (2002) 341-347
    • (2002) Eur. Psychiatry , vol.17 , pp. 341-347
    • Abi-Dargham, A.1
  • 3
    • 1842523130 scopus 로고    scopus 로고
    • Do we still believe in the dopamine hypothesis? New data bring new evidence
    • Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int. J. Neuropsychopharmacol. 7 Suppl. 1 (2004) S1-S5
    • (2004) Int. J. Neuropsychopharmacol. , vol.7 , Issue.SUPPL. 1
    • Abi-Dargham, A.1
  • 4
    • 33847345013 scopus 로고    scopus 로고
    • Alterations of serotonin transmission in schizophrenia
    • Abi-Dargham A. Alterations of serotonin transmission in schizophrenia. Int. Rev. Neurobiol. 78 (2007) 133-164
    • (2007) Int. Rev. Neurobiol. , vol.78 , pp. 133-164
    • Abi-Dargham, A.1
  • 6
    • 33846426067 scopus 로고    scopus 로고
    • Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
    • Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113 (2007) 296-320
    • (2007) Pharmacol. Ther. , vol.113 , pp. 296-320
    • Alex, K.D.1    Pehek, E.A.2
  • 8
  • 9
    • 0028871474 scopus 로고
    • Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system
    • Andersson J.L., Nomikos G.G., Marcus M., Hertel P., Mathe J.M., and Svensson T.H. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Naunyn Schmiedebergs Arch. Pharmacol. 352 (1995) 374-385
    • (1995) Naunyn Schmiedebergs Arch. Pharmacol. , vol.352 , pp. 374-385
    • Andersson, J.L.1    Nomikos, G.G.2    Marcus, M.3    Hertel, P.4    Mathe, J.M.5    Svensson, T.H.6
  • 10
    • 0027199189 scopus 로고
    • (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex
    • Arborelius L., Nomikos G.G., Hacksell U., and Svensson T.H. (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex. Acta Physiol. Scand. 148 (1993) 465-466
    • (1993) Acta Physiol. Scand. , vol.148 , pp. 465-466
    • Arborelius, L.1    Nomikos, G.G.2    Hacksell, U.3    Svensson, T.H.4
  • 11
    • 0023033230 scopus 로고
    • Further studies of the mechanisms behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats
    • Arnt J.H.J., and Bach-Lauritsen T. Further studies of the mechanisms behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats. Acta Pharmacol. Toxicol. (Copenh) 59 (1986) 319-324
    • (1986) Acta Pharmacol. Toxicol. (Copenh) , vol.59 , pp. 319-324
    • Arnt, J.H.J.1    Bach-Lauritsen, T.2
  • 13
    • 0023873890 scopus 로고
    • Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses
    • Baldessarini R.J., Cohen B.M., and Teicher M.H. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch. Gen. Psychiatry 45 (1988) 79-91
    • (1988) Arch. Gen. Psychiatry , vol.45 , pp. 79-91
    • Baldessarini, R.J.1    Cohen, B.M.2    Teicher, M.H.3
  • 14
    • 0018647518 scopus 로고
    • Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy
    • Balsara J.J., Jadhav J.H., and Chandorkar A.G. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology (Berl.) 62 (1979) 67-69
    • (1979) Psychopharmacology (Berl.) , vol.62 , pp. 67-69
    • Balsara, J.J.1    Jadhav, J.H.2    Chandorkar, A.G.3
  • 18
    • 0842264904 scopus 로고    scopus 로고
    • The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice
    • Barr A.M., Lehmann-Masten V., Paulus M., Gainetdinov R.R., Caron M.G., and Geyer M.A. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29 (2004) 221-228
    • (2004) Neuropsychopharmacology , vol.29 , pp. 221-228
    • Barr, A.M.1    Lehmann-Masten, V.2    Paulus, M.3    Gainetdinov, R.R.4    Caron, M.G.5    Geyer, M.A.6
  • 19
    • 33747053349 scopus 로고    scopus 로고
    • Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats
    • Barr A.M., Powell S.B., Markou A., and Geyer M.A. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology 51 (2006) 457-465
    • (2006) Neuropharmacology , vol.51 , pp. 457-465
    • Barr, A.M.1    Powell, S.B.2    Markou, A.3    Geyer, M.A.4
  • 20
    • 34548158648 scopus 로고    scopus 로고
    • Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?
    • Bender S., Weisbrod M., and Resch F. Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?. J. Neural Transm. 114 (2007) 1199-1215
    • (2007) J. Neural Transm. , vol.114 , pp. 1199-1215
    • Bender, S.1    Weisbrod, M.2    Resch, F.3
  • 23
    • 33645242661 scopus 로고    scopus 로고
    • The structure of negative symptoms within schizophrenia: implications for assessment
    • Blanchard J.J., and Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 32 (2006) 238-245
    • (2006) Schizophr. Bull. , vol.32 , pp. 238-245
    • Blanchard, J.J.1    Cohen, A.S.2
  • 26
    • 28044457735 scopus 로고    scopus 로고
    • The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity
    • Bortolozzi A., Diaz-Mataix L., Scorza M.C., Celada P., and Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 95 (2005) 1597-1607
    • (2005) J. Neurochem. , vol.95 , pp. 1597-1607
    • Bortolozzi, A.1    Diaz-Mataix, L.2    Scorza, M.C.3    Celada, P.4    Artigas, F.5
  • 27
    • 0025190458 scopus 로고
    • Sensorimotor gating and schizophrenia. Human and animal model studies
    • Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47 (1990) 181-188
    • (1990) Arch. Gen. Psychiatry , vol.47 , pp. 181-188
    • Braff, D.L.1    Geyer, M.A.2
  • 28
    • 0028855452 scopus 로고
    • Serotonin, schizophrenia and antipsychotic drug action
    • Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophr. Res. 14 (1995) 187-202
    • (1995) Schizophr. Res. , vol.14 , pp. 187-202
    • Breier, A.1
  • 31
    • 33846297688 scopus 로고    scopus 로고
    • Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac?
    • Buckley P.F., and Stahl S.M. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac?. Acta Psychiatr. Scand. 115 (2007) 93-100
    • (2007) Acta Psychiatr. Scand. , vol.115 , pp. 93-100
    • Buckley, P.F.1    Stahl, S.M.2
  • 33
    • 33646152528 scopus 로고    scopus 로고
    • A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
    • Carlsson A., and Carlsson M.L. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin. Neurosci. 8 (2006) 137-142
    • (2006) Dialogues Clin. Neurosci. , vol.8 , pp. 137-142
    • Carlsson, A.1    Carlsson, M.L.2
  • 35
    • 78651116398 scopus 로고
    • Effect of chlorpromazine or haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain
    • Carlsson A.L.M. Effect of chlorpromazine or haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20 (1963) 140-144
    • (1963) Acta Pharmacol. Toxicol. , vol.20 , pp. 140-144
    • Carlsson, A.L.M.1
  • 36
    • 38449084949 scopus 로고    scopus 로고
    • Challenge to atypical antipsychotic drug effect on cognition
    • Carpenter Jr. W.T., and Conley R.R. Challenge to atypical antipsychotic drug effect on cognition. Am. J. Psychiatry 164 (2007) 1910-1911
    • (2007) Am. J. Psychiatry , vol.164 , pp. 1910-1911
    • Carpenter Jr., W.T.1    Conley, R.R.2
  • 38
    • 0025824232 scopus 로고
    • Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics
    • Casey D.E. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics. Psychopharmacol. Bull. 27 (1991) 47-50
    • (1991) Psychopharmacol. Bull. , vol.27 , pp. 47-50
    • Casey, D.E.1
  • 41
    • 0029020015 scopus 로고
    • The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine
    • Cools A.R., Prinssen E.P., and Ellenbroek B.A. The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine. Psychopharmacology (Berl.) 119 (1995) 428-439
    • (1995) Psychopharmacology (Berl.) , vol.119 , pp. 428-439
    • Cools, A.R.1    Prinssen, E.P.2    Ellenbroek, B.A.3
  • 42
    • 1542373740 scopus 로고    scopus 로고
    • Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
    • Correll C.U., Leucht S., and Kane J.M. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am. J. Psychiatry 161 (2004) 414-425
    • (2004) Am. J. Psychiatry , vol.161 , pp. 414-425
    • Correll, C.U.1    Leucht, S.2    Kane, J.M.3
  • 44
    • 0019139272 scopus 로고
    • Positive and negative schizophrenic symptoms and the role of dopamine
    • Crow T.J. Positive and negative schizophrenic symptoms and the role of dopamine. Br. J. Psychiatry 137 (1980) 383-386
    • (1980) Br. J. Psychiatry , vol.137 , pp. 383-386
    • Crow, T.J.1
  • 45
    • 0017727653 scopus 로고
    • The nucleus accumbens - possible site of antipsychotic action of neuroleptic drugs?
    • Crow T.J., Deakin J.F., and Longden A. The nucleus accumbens - possible site of antipsychotic action of neuroleptic drugs?. Psychol. Med. 7 (1977) 213-221
    • (1977) Psychol. Med. , vol.7 , pp. 213-221
    • Crow, T.J.1    Deakin, J.F.2    Longden, A.3
  • 46
    • 0018239823 scopus 로고
    • Neuropharmacological studies on the nigro-striatal and raphe-striatal system in the rat
    • Davies J., and Tongroach P. Neuropharmacological studies on the nigro-striatal and raphe-striatal system in the rat. Eur. J. Pharmacol. 51 (1978) 91-100
    • (1978) Eur. J. Pharmacol. , vol.51 , pp. 91-100
    • Davies, J.1    Tongroach, P.2
  • 48
    • 0032817813 scopus 로고    scopus 로고
    • 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
    • 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J. Neurochem. 73 (1999) 1033-1042
    • (1999) J. Neurochem. , vol.73 , pp. 1033-1042
    • De Deurwaerdere, P.1    Spampinato, U.2
  • 51
    • 0037313398 scopus 로고    scopus 로고
    • 2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study
    • 2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am. J. Psychiatry 160 (2003) 303-309
    • (2003) Am. J. Psychiatry , vol.160 , pp. 303-309
    • de Haan, L.1    van Bruggen, M.2    Lavalaye, J.3    Booij, J.4    Dingemans, P.M.5    Linszen, D.6
  • 52
    • 0033956968 scopus 로고    scopus 로고
    • 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity
    • 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J. Pharmacol. Exp. Ther. 292 (2000) 610-617
    • (2000) J. Pharmacol. Exp. Ther. , vol.292 , pp. 610-617
    • De La Garza II, R.1    Cunningham, K.A.2
  • 53
    • 0024543628 scopus 로고
    • From chlorpromazine to tardive dyskinesia (brief history of neuroleptics)
    • Deniker P. From chlorpromazine to tardive dyskinesia (brief history of neuroleptics). Psychiatr. J. Univ. Ottawa 14 (1989) 253-259
    • (1989) Psychiatr. J. Univ. Ottawa , vol.14 , pp. 253-259
    • Deniker, P.1
  • 54
    • 0025163692 scopus 로고
    • The neuroleptics: a historical survey
    • Deniker P. The neuroleptics: a historical survey. Acta Physiol. Scand. 82 (1990) 83-87
    • (1990) Acta Physiol. Scand. , vol.82 , pp. 83-87
    • Deniker, P.1
  • 55
    • 0025924508 scopus 로고
    • 2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens
    • 2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens. Eur. J. Pharmacol. 192 (1991) 427-429
    • (1991) Eur. J. Pharmacol. , vol.192 , pp. 427-429
    • Devaud, L.L.1    Hollingsworth, E.B.2
  • 61
    • 37549046758 scopus 로고    scopus 로고
    • Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action
    • Di Pietro N.C., and Seamans J.K. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action. Pharmacopsychiatry 40 Suppl. 1 (2007) S27-S33
    • (2007) Pharmacopsychiatry , vol.40 , Issue.SUPPL. 1
    • Di Pietro, N.C.1    Seamans, J.K.2
  • 64
    • 34248534333 scopus 로고    scopus 로고
    • Insights into the role of dopamine receptor systems in learning and memory
    • El-Ghundi M., O'Dowd B.F., and George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18 (2007) 37-66
    • (2007) Rev. Neurosci. , vol.18 , pp. 37-66
    • El-Ghundi, M.1    O'Dowd, B.F.2    George, S.R.3
  • 65
    • 33747173804 scopus 로고    scopus 로고
    • Aripiprazole for schizophrenia. Systematic review
    • El-Sayeh H.G., Morganti C., and Adams C.E. Aripiprazole for schizophrenia. Systematic review. Br. J. Psychiatry 189 (2006) 102-108
    • (2006) Br. J. Psychiatry , vol.189 , pp. 102-108
    • El-Sayeh, H.G.1    Morganti, C.2    Adams, C.E.3
  • 66
    • 0023860186 scopus 로고
    • The paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism
    • Ellenbroek B., and Cools A.R. The paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. Life Sci. 42 (1988) 1205-1213
    • (1988) Life Sci. , vol.42 , pp. 1205-1213
    • Ellenbroek, B.1    Cools, A.R.2
  • 67
    • 0000683636 scopus 로고
    • Animal models with construct validity for schizophrenia
    • Ellenbroek B.A., and Cools A.R. Animal models with construct validity for schizophrenia. Behav. Pharmacol. 1 (1990) 469-490
    • (1990) Behav. Pharmacol. , vol.1 , pp. 469-490
    • Ellenbroek, B.A.1    Cools, A.R.2
  • 68
    • 0030272376 scopus 로고    scopus 로고
    • Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine
    • Ellenbroek B.A., Lubbers L.J., and Cools A.R. Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine. Neuropsychopharmacology 15 (1996) 406-416
    • (1996) Neuropsychopharmacology , vol.15 , pp. 406-416
    • Ellenbroek, B.A.1    Lubbers, L.J.2    Cools, A.R.3
  • 69
    • 0023634681 scopus 로고
    • The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs
    • Ellenbroek B.A., Peeters B.W., Honig W.M., and Cools A.R. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs. Psychopharmacology (Berl.) 93 (1987) 343-348
    • (1987) Psychopharmacology (Berl.) , vol.93 , pp. 343-348
    • Ellenbroek, B.A.1    Peeters, B.W.2    Honig, W.M.3    Cools, A.R.4
  • 70
    • 0028006302 scopus 로고
    • The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats
    • Ellenbroek B.A., Prinssen E.P., and Cools A.R. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats. Eur. J. Neurosci. 6 (1994) 1-8
    • (1994) Eur. J. Neurosci. , vol.6 , pp. 1-8
    • Ellenbroek, B.A.1    Prinssen, E.P.2    Cools, A.R.3
  • 73
  • 74
    • 33644850948 scopus 로고    scopus 로고
    • Serotonin-dopamine interaction as a focus of novel antidepressant drugs
    • Esposito E. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr. Drug Targets 7 (2006) 177-185
    • (2006) Curr. Drug Targets , vol.7 , pp. 177-185
    • Esposito, E.1
  • 76
    • 0026718710 scopus 로고
    • 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
    • 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch. Gen. Psychiatry 49 (1992) 538-544
    • (1992) Arch. Gen. Psychiatry , vol.49 , pp. 538-544
    • Farde, L.1    Nordstrom, A.L.2    Wiesel, F.A.3    Pauli, S.4    Halldin, C.5    Sedvall, G.6
  • 77
    • 37549064027 scopus 로고    scopus 로고
    • 5-HT receptor regulation of neurotransmitter release
    • Fink K.B., and Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev. 59 (2007) 360-417
    • (2007) Pharmacol. Rev. , vol.59 , pp. 360-417
    • Fink, K.B.1    Gothert, M.2
  • 78
    • 0023630323 scopus 로고
    • 2 receptors throughout the rat central nervous system using quantitative autoradiography
    • 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res. 421 (1987) 263-279
    • (1987) Brain Res. , vol.421 , pp. 263-279
    • Fischette, C.T.1    Nock, B.2    Renner, K.3
  • 79
    • 0031005967 scopus 로고    scopus 로고
    • Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes
    • Fleischhacker W.W., and Hummer M. Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes. Drugs 53 (1997) 915-929
    • (1997) Drugs , vol.53 , pp. 915-929
    • Fleischhacker, W.W.1    Hummer, M.2
  • 80
    • 0018687161 scopus 로고
    • The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics
    • Fuenmayor L.D., and Vogt M. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics. Br. J. Pharmacol. 67 (1979) 309-318
    • (1979) Br. J. Pharmacol. , vol.67 , pp. 309-318
    • Fuenmayor, L.D.1    Vogt, M.2
  • 81
    • 0001902397 scopus 로고
    • Drugs antagonistic to 5-hydroxytryptamine
    • Wolstenholme G. (Ed), Little Brown and Co., Boston, MA
    • Gaddum J. Drugs antagonistic to 5-hydroxytryptamine. In: Wolstenholme G. (Ed). Ciba Foundation Symposium on Hypertension (1954), Little Brown and Co., Boston, MA 75-77
    • (1954) Ciba Foundation Symposium on Hypertension , pp. 75-77
    • Gaddum, J.1
  • 82
    • 40949136198 scopus 로고    scopus 로고
    • Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review
    • Gao K., Kemp D.E., Ganocy S.J., Gajwani P., Xia G., and Calabrese J.R. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J. Clin. Psychopharmacol. 28 (2008) 203-209
    • (2008) J. Clin. Psychopharmacol. , vol.28 , pp. 203-209
    • Gao, K.1    Kemp, D.E.2    Ganocy, S.J.3    Gajwani, P.4    Xia, G.5    Calabrese, J.R.6
  • 84
    • 0034598111 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
    • Geddes J., Freemantle N., Harrison P., and Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321 (2000) 1371-1376
    • (2000) BMJ , vol.321 , pp. 1371-1376
    • Geddes, J.1    Freemantle, N.2    Harrison, P.3    Bebbington, P.4
  • 85
    • 0024366801 scopus 로고
    • Thymosthenic agents, a novel approach in the treatment of schizophrenia
    • Gelders Y.G. Thymosthenic agents, a novel approach in the treatment of schizophrenia. Br. J. Psychiatry 155 Suppl. (1989) 33-36
    • (1989) Br. J. Psychiatry , vol.155 , Issue.SUPPL , pp. 33-36
    • Gelders, Y.G.1
  • 86
    • 0022414990 scopus 로고
    • The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form
    • George S.R., Watanabe M., Di Paolo T., Falardeau P., Labrie F., and Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology 117 (1985) 690-697
    • (1985) Endocrinology , vol.117 , pp. 690-697
    • George, S.R.1    Watanabe, M.2    Di Paolo, T.3    Falardeau, P.4    Labrie, F.5    Seeman, P.6
  • 89
    • 33947507311 scopus 로고    scopus 로고
    • The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?
    • Geyer M.A. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?. Neurotox. Res. 10 (2006) 211-220
    • (2006) Neurotox. Res. , vol.10 , pp. 211-220
    • Geyer, M.A.1
  • 90
    • 0345690103 scopus 로고    scopus 로고
    • Animal behavior models of the mechanisms underlying antipsychotic atypicality
    • Geyer M.A., and Ellenbroek B. Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 1071-1079
    • (2003) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.27 , pp. 1071-1079
    • Geyer, M.A.1    Ellenbroek, B.2
  • 91
    • 0018248907 scopus 로고
    • Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites
    • Giambalvo C.T., and Snodgrass S.R. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites. Brain Res. 152 (1978) 555-566
    • (1978) Brain Res. , vol.152 , pp. 555-566
    • Giambalvo, C.T.1    Snodgrass, S.R.2
  • 92
    • 0027533244 scopus 로고
    • Recent advances in the molecular biology of dopamine receptors
    • Gingrich J.A., and Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16 (1993) 299-321
    • (1993) Annu. Rev. Neurosci. , vol.16 , pp. 299-321
    • Gingrich, J.A.1    Caron, M.G.2
  • 96
    • 33847400445 scopus 로고    scopus 로고
    • The dopamine system and the pathophysiology of schizophrenia: a basic science perspective
    • Goto Y., and Grace A.A. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int. Rev. Neurobiol. 78 (2007) 41-68
    • (2007) Int. Rev. Neurobiol. , vol.78 , pp. 41-68
    • Goto, Y.1    Grace, A.A.2
  • 97
    • 0026059697 scopus 로고
    • Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia
    • Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 (1991) 1-24
    • (1991) Neuroscience , vol.41 , pp. 1-24
    • Grace, A.A.1
  • 98
    • 0021718376 scopus 로고
    • The control of firing pattern in nigral dopamine neurons: burst firing
    • Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4 (1984) 2877-2890
    • (1984) J. Neurosci. , vol.4 , pp. 2877-2890
    • Grace, A.A.1    Bunney, B.S.2
  • 99
    • 0021714346 scopus 로고
    • The control of firing pattern in nigral dopamine neurons: single spike firing
    • Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4 (1984) 2866-2876
    • (1984) J. Neurosci. , vol.4 , pp. 2866-2876
    • Grace, A.A.1    Bunney, B.S.2
  • 101
    • 34548348729 scopus 로고    scopus 로고
    • Molecular targets for treating cognitive dysfunction in schizophrenia
    • Gray J.A., and Roth B.L. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 33 (2007) 1100-1119
    • (2007) Schizophr. Bull. , vol.33 , pp. 1100-1119
    • Gray, J.A.1    Roth, B.L.2
  • 102
    • 0029918481 scopus 로고    scopus 로고
    • What are the functional consequences of neurocognitive deficits in schizophrenia?
    • Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 153 (1996) 321-330
    • (1996) Am. J. Psychiatry , vol.153 , pp. 321-330
    • Green, M.F.1
  • 104
    • 7544250144 scopus 로고    scopus 로고
    • The MATRICS initiative: developing a consensus cognitive battery for clinical trials
    • Green M.F., and Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 72 (2004) 1-3
    • (2004) Schizophr. Res. , vol.72 , pp. 1-3
    • Green, M.F.1    Nuechterlein, K.H.2
  • 105
    • 26444444254 scopus 로고    scopus 로고
    • Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy
    • Greenwood K.E., Landau S., and Wykes T. Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy. Schizophr. Bull. 31 (2005) 910-921
    • (2005) Schizophr. Bull. , vol.31 , pp. 910-921
    • Greenwood, K.E.1    Landau, S.2    Wykes, T.3
  • 107
    • 4644250170 scopus 로고    scopus 로고
    • Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders
    • Gupta S., and Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann. Clin. Psychiatry 16 (2004) 155-166
    • (2004) Ann. Clin. Psychiatry , vol.16 , pp. 155-166
    • Gupta, S.1    Masand, P.2
  • 108
    • 6344253360 scopus 로고    scopus 로고
    • Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management
    • Haddad P.M., and Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 64 (2004) 2291-2314
    • (2004) Drugs , vol.64 , pp. 2291-2314
    • Haddad, P.M.1    Wieck, A.2
  • 109
    • 26444457491 scopus 로고    scopus 로고
    • Predicting drug efficacy for cognitive deficits in schizophrenia
    • Hagan J.J., and Jones D.N. Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr. Bull. 31 (2005) 830-853
    • (2005) Schizophr. Bull. , vol.31 , pp. 830-853
    • Hagan, J.J.1    Jones, D.N.2
  • 111
    • 33645230162 scopus 로고    scopus 로고
    • Negative symptoms and cognitive deficits: what is the nature of their relationship?
    • Harvey P.D., Koren D., Reichenberg A., and Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 32 (2006) 250-258
    • (2006) Schizophr. Bull. , vol.32 , pp. 250-258
    • Harvey, P.D.1    Koren, D.2    Reichenberg, A.3    Bowie, C.R.4
  • 113
    • 0025242104 scopus 로고
    • The effect of serotonergic agents on haloperidol-induced catalepsy
    • Hicks P.B. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 47 (1990) 1609-1615
    • (1990) Life Sci. , vol.47 , pp. 1609-1615
    • Hicks, P.B.1
  • 115
    • 0033045962 scopus 로고    scopus 로고
    • A historical perspective of clozapine
    • Hippius H. A historical perspective of clozapine. J. Clin. Psychiatry 60 Suppl. 12 (1999) 22-23
    • (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 12 , pp. 22-23
    • Hippius, H.1
  • 116
    • 0030439221 scopus 로고    scopus 로고
    • Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization
    • Iyer R.N., and Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 277 (1996) 40-47
    • (1996) J. Pharmacol. Exp. Ther. , vol.277 , pp. 40-47
    • Iyer, R.N.1    Bradberry, C.W.2
  • 117
    • 0019152171 scopus 로고
    • Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum
    • James T.A., and Starr M.S. Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J. Pharm. Pharmacol. 32 (1980) 196-200
    • (1980) J. Pharm. Pharmacol. , vol.32 , pp. 196-200
    • James, T.A.1    Starr, M.S.2
  • 119
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
    • Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45 (1988) 789-796
    • (1988) Arch. Gen. Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 120
    • 33748336475 scopus 로고    scopus 로고
    • Tardive dyskinesia circa 2006
    • Kane J.M. Tardive dyskinesia circa 2006. Am. J. Psychiatry 163 (2006) 1316-1318
    • (2006) Am. J. Psychiatry , vol.163 , pp. 1316-1318
    • Kane, J.M.1
  • 121
    • 0036007937 scopus 로고    scopus 로고
    • 3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat
    • 3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology (Berl.) 159 (2002) 341-350
    • (2002) Psychopharmacology (Berl.) , vol.159 , pp. 341-350
    • Kankaanpaa, A.1    Meririnne, E.2    Seppala, T.3
  • 122
    • 0029988896 scopus 로고    scopus 로고
    • Serotonin-dopamine interaction and its relevance to schizophrenia
    • Kapur S., and Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153 (1996) 466-476
    • (1996) Am. J. Psychiatry , vol.153 , pp. 466-476
    • Kapur, S.1    Remington, G.2
  • 123
    • 0035660215 scopus 로고    scopus 로고
    • 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient
    • 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol. Psychiatry 50 (2001) 873-883
    • (2001) Biol. Psychiatry , vol.50 , pp. 873-883
    • Kapur, S.1    Remington, G.2
  • 124
    • 0029026941 scopus 로고
    • 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study
    • 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci. 57 (1995) 103-107
    • (1995) Life Sci. , vol.57 , pp. 103-107
    • Kapur, S.1    Remington, G.2    Zipursky, R.B.3    Wilson, A.A.4    Houle, S.5
  • 125
    • 0035094264 scopus 로고    scopus 로고
    • 2 receptor explain the action of atypical antipsychotics? A new hypothesis
    • 2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am. J. Psychiatry 158 (2001) 360-369
    • (2001) Am. J. Psychiatry , vol.158 , pp. 360-369
    • Kapur, S.1    Seeman, P.2
  • 126
    • 0034025771 scopus 로고    scopus 로고
    • 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia
    • 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry 157 (2000) 514-520
    • (2000) Am. J. Psychiatry , vol.157 , pp. 514-520
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Remington, G.4    Houle, S.5
  • 129
    • 0032982714 scopus 로고    scopus 로고
    • 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
    • 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am. J. Psychiatry 156 (1999) 286-293
    • (1999) Am. J. Psychiatry , vol.156 , pp. 286-293
    • Kapur, S.1    Zipursky, R.B.2    Remington, G.3
  • 131
    • 34648816582 scopus 로고    scopus 로고
    • 2 receptor partial agonism?
    • 2 receptor partial agonism?. Am. J. Psychiatry 164 (2007) 1310-1312
    • (2007) Am. J. Psychiatry , vol.164 , pp. 1310-1312
    • Kessler, R.M.1
  • 132
    • 33645229623 scopus 로고    scopus 로고
    • The factorial structure of the schedule for the deficit syndrome in schizophrenia
    • Kimhy D., Yale S., Goetz R.R., McFarr L.M., and Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophr. Bull. 32 (2006) 274-278
    • (2006) Schizophr. Bull. , vol.32 , pp. 274-278
    • Kimhy, D.1    Yale, S.2    Goetz, R.R.3    McFarr, L.M.4    Malaspina, D.5
  • 134
    • 33645241774 scopus 로고    scopus 로고
    • Subdomains within the negative symptoms of schizophrenia: commentary
    • Kirkpatrick B., and Fischer B. Subdomains within the negative symptoms of schizophrenia: commentary. Schizophr. Bull. 32 (2006) 246-249
    • (2006) Schizophr. Bull. , vol.32 , pp. 246-249
    • Kirkpatrick, B.1    Fischer, B.2
  • 136
    • 0003530957 scopus 로고
    • Krieger Publishing Co., Melbourne, FL. original published in 1919
    • Kraepelin E. Dementia Praecox and Paraphrenia. (1971), Krieger Publishing Co., Melbourne, FL. original published in 1919
    • (1971) Dementia Praecox and Paraphrenia.
    • Kraepelin, E.1
  • 137
    • 33645221984 scopus 로고    scopus 로고
    • Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim
    • Laughren T., and Levin R. Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim. Schizophr. Bull. 32 (2006) 220-222
    • (2006) Schizophr. Bull. , vol.32 , pp. 220-222
    • Laughren, T.1    Levin, R.2
  • 138
    • 0038107717 scopus 로고    scopus 로고
    • 6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine
    • 6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol. Biochem. Behav. 75 (2003) 281-288
    • (2003) Pharmacol. Biochem. Behav. , vol.75 , pp. 281-288
    • Leng, A.1    Ouagazzal, A.2    Feldon, J.3    Higgins, G.A.4
  • 139
    • 0029806639 scopus 로고    scopus 로고
    • Movement disorders associated with the serotonin selective reuptake inhibitors
    • Leo R.J. Movement disorders associated with the serotonin selective reuptake inhibitors. J. Clin. Psychiatry 57 (1996) 449-454
    • (1996) J. Clin. Psychiatry , vol.57 , pp. 449-454
    • Leo, R.J.1
  • 140
    • 0036161972 scopus 로고    scopus 로고
    • Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials
    • Leucht S., Pitschel-Walz G., Engel R.R., and Kissling W. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Am. J. Psychiatry 159 (2002) 180-190
    • (2002) Am. J. Psychiatry , vol.159 , pp. 180-190
    • Leucht, S.1    Pitschel-Walz, G.2    Engel, R.R.3    Kissling, W.4
  • 141
    • 0038582771 scopus 로고    scopus 로고
    • New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
    • Leucht S., Wahlbeck K., Hamann J., and Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361 (2003) 1581-1589
    • (2003) Lancet , vol.361 , pp. 1581-1589
    • Leucht, S.1    Wahlbeck, K.2    Hamann, J.3    Kissling, W.4
  • 142
    • 0036308284 scopus 로고    scopus 로고
    • Schizophrenia as a disorder of neurodevelopment
    • Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25 (2002) 409-432
    • (2002) Annu. Rev. Neurosci. , vol.25 , pp. 409-432
    • Lewis, D.A.1    Levitt, P.2
  • 143
    • 40449123512 scopus 로고    scopus 로고
    • CATIE and CUtLASS: can we handle the truth?
    • Lewis S., and Lieberman J. CATIE and CUtLASS: can we handle the truth?. Br. J. Psychiatry 192 (2008) 161-163
    • (2008) Br. J. Psychiatry , vol.192 , pp. 161-163
    • Lewis, S.1    Lieberman, J.2
  • 144
    • 0032821589 scopus 로고    scopus 로고
    • Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective
    • Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 46 (1999) 729-739
    • (1999) Biol. Psychiatry , vol.46 , pp. 729-739
    • Lieberman, J.A.1
  • 145
    • 0037199768 scopus 로고    scopus 로고
    • 2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner
    • 2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. Brain Res. 947 (2002) 157-165
    • (2002) Brain Res. , vol.947 , pp. 157-165
    • Liegeois, J.F.1    Ichikawa, J.2    Meltzer, H.Y.3
  • 147
    • 0033842215 scopus 로고    scopus 로고
    • Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated
    • Lucas G., De Deurwaerdere P., Porras G., and Spampinato U. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology 39 (2000) 1984-1995
    • (2000) Neuropharmacology , vol.39 , pp. 1984-1995
    • Lucas, G.1    De Deurwaerdere, P.2    Porras, G.3    Spampinato, U.4
  • 148
    • 0033621576 scopus 로고    scopus 로고
    • 2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum
    • 2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J. Neurochem. 74 (2000) 693-701
    • (2000) J. Neurochem. , vol.74 , pp. 693-701
    • Lucas, G.1    Spampinato, U.2
  • 149
    • 33748531860 scopus 로고    scopus 로고
    • Drug initiatives to improve cognitive function
    • Marder S.R. Drug initiatives to improve cognitive function. J. Clin. Psychiatry 67 Suppl. 9 (2006) 31-35
    • (2006) J. Clin. Psychiatry , vol.67 , Issue.SUPPL. 9 , pp. 31-35
    • Marder, S.R.1
  • 150
    • 39049178348 scopus 로고    scopus 로고
    • Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness
    • Marder S.R. Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness. J. Clin. Psychiatry 67 Suppl. 9 (2006) e03
    • (2006) J. Clin. Psychiatry , vol.67 , Issue.SUPPL. 9
    • Marder, S.R.1
  • 151
    • 0028342655 scopus 로고
    • Risperidone in the treatment of schizophrenia
    • Marder S.R., and Meibach R.C. Risperidone in the treatment of schizophrenia. Am. J. Psychiatry 151 (1994) 825-835
    • (1994) Am. J. Psychiatry , vol.151 , pp. 825-835
    • Marder, S.R.1    Meibach, R.C.2
  • 152
    • 33847421275 scopus 로고    scopus 로고
    • Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development
    • Marek G.J. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development. Int. Rev. Neurobiol. 78 (2007) 165-192
    • (2007) Int. Rev. Neurobiol. , vol.78 , pp. 165-192
    • Marek, G.J.1
  • 156
  • 158
    • 0002629884 scopus 로고
    • Atypical antipsychotic drugs
    • Kupfer D., and Bloom F.E. (Eds), Raven Press, New York, NY
    • Meltzer H. Atypical antipsychotic drugs. In: Kupfer D., and Bloom F.E. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York, NY 1277-1286
    • (1995) Psychopharmacology: The Fourth Generation of Progress , pp. 1277-1286
    • Meltzer, H.1
  • 162
    • 0020040075 scopus 로고
    • Disruption of primate social behavior by D-amphetamine and cocaine: differential antagonism by antipsychotics
    • Miczek K.A., and Yoshimura H. Disruption of primate social behavior by D-amphetamine and cocaine: differential antagonism by antipsychotics. Psychopharmacology (Berl.) 76 (1982) 163-171
    • (1982) Psychopharmacology (Berl.) , vol.76 , pp. 163-171
    • Miczek, K.A.1    Yoshimura, H.2
  • 166
    • 0035077696 scopus 로고    scopus 로고
    • 2A receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study
    • 2A receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study. Synapse 40 (2004) 102-112
    • (2004) Synapse , vol.40 , pp. 102-112
    • Minabe, Y.1    Hashimoto, K.2    Watanabe, K.I.3    Ashby, C.R.Jr.4
  • 167
    • 4344693762 scopus 로고    scopus 로고
    • 2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex
    • 2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29 (2004) 1637-1647
    • (2004) Neuropsychopharmacology , vol.29 , pp. 1637-1647
    • Mirjana, C.1    Baviera, M.2    Invernizzi, R.W.3    Balducci, C.4
  • 168
    • 12344326514 scopus 로고    scopus 로고
    • Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
    • Miyamoto S., Duncan G.E., Marx C.E., and Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 10 (2005) 79-104
    • (2005) Mol. Psychiatry , vol.10 , pp. 79-104
    • Miyamoto, S.1    Duncan, G.E.2    Marx, C.E.3    Lieberman, J.A.4
  • 169
    • 0019188610 scopus 로고
    • From motivation to action: functional interface between the limbic system and the motor system
    • Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14 (1980) 69-97
    • (1980) Prog. Neurobiol. , vol.14 , pp. 69-97
    • Mogenson, G.J.1    Jones, D.L.2    Yim, C.Y.3
  • 170
    • 0023155574 scopus 로고
    • Interactions between prolactin and dopaminergic neurons
    • Moore K.E. Interactions between prolactin and dopaminergic neurons. Biol. Reprod. 36 (1987) 47-58
    • (1987) Biol. Reprod. , vol.36 , pp. 47-58
    • Moore, K.E.1
  • 171
    • 0033214515 scopus 로고    scopus 로고
    • Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats
    • Morrow B.A., Rosenberg S.J., and Roth R.H. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats. Synapse 34 (1999) 28-35
    • (1999) Synapse , vol.34 , pp. 28-35
    • Morrow, B.A.1    Rosenberg, S.J.2    Roth, R.H.3
  • 172
    • 0842286591 scopus 로고    scopus 로고
    • 2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum
    • 2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29 (2004) 319-326
    • (2004) Neuropsychopharmacology , vol.29 , pp. 319-326
    • Navailles, S.1    De Deurwaerdere, P.2    Porras, G.3    Spampinato, U.4
  • 175
    • 34347336444 scopus 로고    scopus 로고
    • Neuropharmacological profile of bifeprunox: merits and limitations in comparison with other third-generation antipsychotics
    • Newman-Tancredi A., Cussac D., and Depoortere R. Neuropharmacological profile of bifeprunox: merits and limitations in comparison with other third-generation antipsychotics. Curr. Opin. Investig. Drugs 8 (2007) 539-554
    • (2007) Curr. Opin. Investig. Drugs , vol.8 , pp. 539-554
    • Newman-Tancredi, A.1    Cussac, D.2    Depoortere, R.3
  • 178
    • 6344256332 scopus 로고    scopus 로고
    • 1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels
    • 1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. J. Pharmacol. Exp. Ther. 311 (2004) 711-719
    • (2004) J. Pharmacol. Exp. Ther. , vol.311 , pp. 711-719
    • O'Dell, L.E.1    Parsons, L.H.2
  • 179
    • 3242790211 scopus 로고    scopus 로고
    • Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex
    • Ojima T., Ito C., Sakurai E., Sakurai E., Watanabe T., and Yanai K. Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex. Neurosci. Lett. 366 (2004) 130-134
    • (2004) Neurosci. Lett. , vol.366 , pp. 130-134
    • Ojima, T.1    Ito, C.2    Sakurai, E.3    Sakurai, E.4    Watanabe, T.5    Yanai, K.6
  • 182
    • 0033560989 scopus 로고    scopus 로고
    • 1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine
    • 1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine. Synapse 32 (1999) 132-135
    • (1999) Synapse , vol.32 , pp. 132-135
    • Parsons, L.H.1    Koob, G.F.2    Weiss, F.3
  • 185
    • 0029938033 scopus 로고    scopus 로고
    • Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects
    • Peacock L., Solgaard T., Lublin H., and Gerlach J. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects. Psychopharmacology (Berl.) 124 (1996) 188-196
    • (1996) Psychopharmacology (Berl.) , vol.124 , pp. 188-196
    • Peacock, L.1    Solgaard, T.2    Lublin, H.3    Gerlach, J.4
  • 187
    • 30544447091 scopus 로고    scopus 로고
    • Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice
    • Pires J.G., Bonikovski V., and Futuro-Neto H.A. Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Braz. J. Med. Biol. Res. 38 (2005) 1867-1872
    • (2005) Braz. J. Med. Biol. Res. , vol.38 , pp. 1867-1872
    • Pires, J.G.1    Bonikovski, V.2    Futuro-Neto, H.A.3
  • 188
    • 0026565253 scopus 로고
    • 1A receptor in the rat brain: correlation with receptor binding
    • 1A receptor in the rat brain: correlation with receptor binding. J. Neurosci. 12 (1992) 440-453
    • (1992) J. Neurosci. , vol.12 , pp. 440-453
    • Pompeiano, M.1    Palacios, J.M.2    Mengod, G.3
  • 190
    • 0036886022 scopus 로고    scopus 로고
    • 4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine
    • 4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology 43 (2002) 1099-1109
    • (2002) Neuropharmacology , vol.43 , pp. 1099-1109
    • Porras, G.1    Di Matteo, V.2    De Deurwaerdere, P.3    Esposito, E.4    Spampinato, U.5
  • 192
    • 0036314871 scopus 로고    scopus 로고
    • 2C receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex
    • 2C receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J. Neurochem. 82 (2002) 93-100
    • (2002) J. Neurochem. , vol.82 , pp. 93-100
    • Pozzi, L.1    Acconcia, S.2    Ceglia, I.3    Invernizzi, R.W.4    Samanin, R.5
  • 193
    • 34147160638 scopus 로고    scopus 로고
    • Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis
    • Pukrop R., Ruhrmann S., Schultze-Lutter F., Bechdolf A., Brockhaus-Dumke A., and Klosterkotter J. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr. Res. 92 (2007) 116-125
    • (2007) Schizophr. Res. , vol.92 , pp. 116-125
    • Pukrop, R.1    Ruhrmann, S.2    Schultze-Lutter, F.3    Bechdolf, A.4    Brockhaus-Dumke, A.5    Klosterkotter, J.6
  • 196
    • 0141455897 scopus 로고    scopus 로고
    • Understanding antipsychotic "atypicality": a clinical and pharmacological moving target
    • Remington G. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target. J. Psychiatry Neurosci. 28 (2003) 275-284
    • (2003) J. Psychiatry Neurosci. , vol.28 , pp. 275-284
    • Remington, G.1
  • 197
    • 33846837063 scopus 로고    scopus 로고
    • Tardive dyskinesia: eliminated, forgotten, or overshadowed?
    • Remington G. Tardive dyskinesia: eliminated, forgotten, or overshadowed?. Curr. Opin. Psychiatry 20 (2007) 131-137
    • (2007) Curr. Opin. Psychiatry , vol.20 , pp. 131-137
    • Remington, G.1
  • 198
    • 0032934615 scopus 로고    scopus 로고
    • 2 receptor effects of antipsychotics: bridging basic and clinical findings using PET
    • 2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. J. Clin. Psychiatry 60 Suppl. 10 (1999) 15-19
    • (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 10 , pp. 15-19
    • Remington, G.1    Kapur, S.2
  • 199
    • 0033983417 scopus 로고    scopus 로고
    • Atypical antipsychotics: are some more atypical than others?
    • Remington G., and Kapur S. Atypical antipsychotics: are some more atypical than others?. Psychopharmacology (Berl.) 148 (2000) 3-15
    • (2000) Psychopharmacology (Berl.) , vol.148 , pp. 3-15
    • Remington, G.1    Kapur, S.2
  • 200
    • 31344459099 scopus 로고    scopus 로고
    • Augmentation strategies in treatment-resistant schizophrenia
    • Remington G., Saha A., Chong S.A., and Shammi C. Augmentation strategies in treatment-resistant schizophrenia. CNS Drugs 19 (2005) 843-872
    • (2005) CNS Drugs , vol.19 , pp. 843-872
    • Remington, G.1    Saha, A.2    Chong, S.A.3    Shammi, C.4
  • 202
    • 1542313966 scopus 로고    scopus 로고
    • Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder
    • Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., and Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 161 (2004) 473-479
    • (2004) Am. J. Psychiatry , vol.161 , pp. 473-479
    • Robinson, D.G.1    Woerner, M.G.2    McMeniman, M.3    Mendelowitz, A.4    Bilder, R.M.5
  • 203
    • 0034254353 scopus 로고    scopus 로고
    • 1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
    • 1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol. Psychiatry 48 (2000) 229-237
    • (2000) Biol. Psychiatry , vol.48 , pp. 229-237
    • Rollema, H.1    Lu, Y.2    Schmidt, A.W.3    Sprouse, J.S.4    Zorn, S.H.5
  • 205
    • 0001792366 scopus 로고
    • The role of serotonin in schizophrenia
    • Bloom F.E., and Kupfer D. (Eds), Raven Press, Ltd., New York, NY
    • Roth B.L., and Meltzer H.Y. The role of serotonin in schizophrenia. In: Bloom F.E., and Kupfer D. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, Ltd., New York, NY 1215-1227
    • (1995) Psychopharmacology: The Fourth Generation of Progress , pp. 1215-1227
    • Roth, B.L.1    Meltzer, H.Y.2
  • 207
    • 0030071335 scopus 로고    scopus 로고
    • Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia
    • Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmacol. 7 (1996) 3-23
    • (1996) Behav. Pharmacol. , vol.7 , pp. 3-23
    • Sams-Dodd, F.1
  • 209
    • 34447095484 scopus 로고    scopus 로고
    • Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications
    • Savina I., and Beninger R.J. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications. Schizophr. Res. 94 (2007) 128-138
    • (2007) Schizophr. Res. , vol.94 , pp. 128-138
    • Savina, I.1    Beninger, R.J.2
  • 211
    • 0028176861 scopus 로고
    • 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
    • 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem. 62 (1994) 1382-1389
    • (1994) J. Neurochem. , vol.62 , pp. 1382-1389
    • Schmidt, C.J.1    Sullivan, C.K.2    Fadayel, G.M.3
  • 212
    • 0027468102 scopus 로고
    • Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task
    • Schultz W., Apicella P., and Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13 (1993) 900-913
    • (1993) J. Neurosci. , vol.13 , pp. 900-913
    • Schultz, W.1    Apicella, P.2    Ljungberg, T.3
  • 213
    • 0036221550 scopus 로고    scopus 로고
    • Atypical antipsychotics: mechanism of action
    • Seeman P. Atypical antipsychotics: mechanism of action. Can. J. Psychiatry 47 (2002) 27-38
    • (2002) Can. J. Psychiatry , vol.47 , pp. 27-38
    • Seeman, P.1
  • 214
    • 50349091629 scopus 로고    scopus 로고
    • Dopamine receptors, schizophrenia and antipsychotics
    • Seeman P. Dopamine receptors, schizophrenia and antipsychotics. Can. J. Diagn. January (2006) 1-7
    • (2006) Can. J. Diagn. , Issue.January , pp. 1-7
    • Seeman, P.1
  • 215
    • 0017068246 scopus 로고
    • Antipsychotic drug doses and neuroleptic/dopamine receptors
    • Seeman P., Lee T., Chau-Wong M., and Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
    • (1976) Nature , vol.261 , pp. 717-719
    • Seeman, P.1    Lee, T.2    Chau-Wong, M.3    Wong, K.4
  • 217
    • 0031953450 scopus 로고    scopus 로고
    • 2 receptors, yet occupy high levels of these receptors
    • 2 receptors, yet occupy high levels of these receptors. Mol. Psychiatry 3 (1998) 123-134
    • (1998) Mol. Psychiatry , vol.3 , pp. 123-134
    • Seeman, P.1    Tallerico, T.2
  • 218
    • 0032973806 scopus 로고    scopus 로고
    • 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
    • 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am. J. Psychiatry 156 (1999) 876-884
    • (1999) Am. J. Psychiatry , vol.156 , pp. 876-884
    • Seeman, P.1    Tallerico, T.2
  • 219
    • 34247538931 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis
    • Sepehry A.A., Potvin S., Elie R., and Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J. Clin. Psychiatry 68 (2007) 604-610
    • (2007) J. Clin. Psychiatry , vol.68 , pp. 604-610
    • Sepehry, A.A.1    Potvin, S.2    Elie, R.3    Stip, E.4
  • 227
    • 40349103296 scopus 로고    scopus 로고
    • Schizophrenia genetics: the search for a hard lead
    • Sullivan P.F. Schizophrenia genetics: the search for a hard lead. Curr. Opin. Psychiatry 21 (2008) 157-160
    • (2008) Curr. Opin. Psychiatry , vol.21 , pp. 157-160
    • Sullivan, P.F.1
  • 228
    • 0036202379 scopus 로고    scopus 로고
    • Partial dopamine agonists in the treatment of psychosis
    • Tamminga C.A. Partial dopamine agonists in the treatment of psychosis. J. Neural Transm. 109 (2002) 411-420
    • (2002) J. Neural Transm. , vol.109 , pp. 411-420
    • Tamminga, C.A.1
  • 229
    • 0028989953 scopus 로고
    • 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex
    • 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology (Berl.) 119 (1995) 15-19
    • (1995) Psychopharmacology (Berl.) , vol.119 , pp. 15-19
    • Tanda, G.1    Frau, R.2    Di Chiara, G.3
  • 233
  • 234
    • 0002600739 scopus 로고
    • The significance of dopamine-receptor blockade for the action of neuroleptic drugs
    • Coyle J., Brill H., Deniker P., Hippius H., and Bradley P.B. (Eds), Excerptica Medica, Amsterdam
    • Van Rossum J. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Coyle J., Brill H., Deniker P., Hippius H., and Bradley P.B. (Eds). Neuropsychopharmacology, Proceedings of the 5th Collegium Internationale Neuro-psychopharmacologicum (CINP) (1967), Excerptica Medica, Amsterdam 321-329
    • (1967) Neuropsychopharmacology, Proceedings of the 5th Collegium Internationale Neuro-psychopharmacologicum (CINP) , pp. 321-329
    • Van Rossum, J.1
  • 235
    • 33646709186 scopus 로고    scopus 로고
    • Schizophrenia: who is at risk? Who is a case?
    • Verdoux H., and Cougnard A. Schizophrenia: who is at risk? Who is a case?. Int. Clin. Psychopharmacol. 21 Suppl. 2 (2006) S17-S19
    • (2006) Int. Clin. Psychopharmacol. , vol.21 , Issue.SUPPL. 2
    • Verdoux, H.1    Cougnard, A.2
  • 239
    • 33750626892 scopus 로고    scopus 로고
    • Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia - findings from an in vivo SPECT study
    • Voruganti L.N., and Awad A.G. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia - findings from an in vivo SPECT study. Schizophr Res. 88 (2006) 179-186
    • (2006) Schizophr Res. , vol.88 , pp. 179-186
    • Voruganti, L.N.1    Awad, A.G.2
  • 240
    • 0031953485 scopus 로고    scopus 로고
    • Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?
    • Waddington J.L., Lane A., Scully P.J., Larkin C., and O'Callaghan E. Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?. Psychiatr. Clin. N. Am. 21 (1998) 123-149
    • (1998) Psychiatr. Clin. N. Am. , vol.21 , pp. 123-149
    • Waddington, J.L.1    Lane, A.2    Scully, P.J.3    Larkin, C.4    O'Callaghan, E.5
  • 241
    • 0026701850 scopus 로고
    • Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat
    • Wadenberg M.L. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat. J. Neural Transm. Gen. Sect. 89 (1992) 49-59
    • (1992) J. Neural Transm. Gen. Sect. , vol.89 , pp. 49-59
    • Wadenberg, M.L.1
  • 242
    • 0018398866 scopus 로고
    • Serotonin-dopamine interactions in the nigrostriatal system
    • Waldmeier P.C., and Delini-Stula A.A. Serotonin-dopamine interactions in the nigrostriatal system. Eur. J. Pharmacol. 55 (1979) 363-373
    • (1979) Eur. J. Pharmacol. , vol.55 , pp. 363-373
    • Waldmeier, P.C.1    Delini-Stula, A.A.2
  • 243
    • 0036689288 scopus 로고    scopus 로고
    • Risk factors and the neurodevelopmental course of schizophrenia
    • Walker E. Risk factors and the neurodevelopmental course of schizophrenia. Eur. Psychiatry 17 (2002) 363-369
    • (2002) Eur. Psychiatry , vol.17 , pp. 363-369
    • Walker, E.1
  • 244
    • 0023215296 scopus 로고
    • Implications of normal brain development for the pathogenesis of schizophrenia
    • Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987) 660-669
    • (1987) Arch. Gen. Psychiatry , vol.44 , pp. 660-669
    • Weinberger, D.R.1
  • 245
    • 0023918477 scopus 로고
    • Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism
    • Weinberger D.R., Berman K.F., and Illowsky B.P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45 (1988) 609-615
    • (1988) Arch. Gen. Psychiatry , vol.45 , pp. 609-615
    • Weinberger, D.R.1    Berman, K.F.2    Illowsky, B.P.3
  • 247
    • 0000358118 scopus 로고
    • A biochemical and pharmacological suggestion about certain mental disorders
    • Woolley D.W., and Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. U.S.A. 40 (1954) 228-231
    • (1954) Proc. Natl. Acad. Sci. U.S.A. , vol.40 , pp. 228-231
    • Woolley, D.W.1    Shaw, E.2
  • 250
    • 0029037007 scopus 로고
    • Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra
    • Yamamoto B.K., Nash J.F., and Gudelsky G.A. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J. Pharmacol. Exp. Ther. 273 (1995) 1063-1070
    • (1995) J. Pharmacol. Exp. Ther. , vol.273 , pp. 1063-1070
    • Yamamoto, B.K.1    Nash, J.F.2    Gudelsky, G.A.3
  • 252
    • 0034285086 scopus 로고    scopus 로고
    • Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex
    • Zhang W., Perry K.W., Wong D.T., Potts B.D., Bao J., Tollefson G.D., and Bymaster F.P. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 23 (2000) 250-262
    • (2000) Neuropsychopharmacology , vol.23 , pp. 250-262
    • Zhang, W.1    Perry, K.W.2    Wong, D.T.3    Potts, B.D.4    Bao, J.5    Tollefson, G.D.6    Bymaster, F.P.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.